These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 35680102)
1. WCK 4034: A promising oxazolidinone for treating gram positive infections. Bhawsar S; Pawar S; Deshpande P; Yeole R; Chavan R; Nandanwar M; Bhagwat S; Patel M Bioorg Med Chem Lett; 2022 Sep; 71():128842. PubMed ID: 35680102 [TBL] [Abstract][Full Text] [Related]
2. In vivo activity of the pyrrolopyrazolyl-substituted oxazolidinone RWJ-416457. Hilliard JJ; Fernandez J; Melton J; Macielag MJ; Goldschmidt R; Bush K; Abbanat D Antimicrob Agents Chemother; 2009 May; 53(5):2028-33. PubMed ID: 19273686 [TBL] [Abstract][Full Text] [Related]
3. In vivo pharmacodynamics of torezolid phosphate (TR-701), a new oxazolidinone antibiotic, against methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains in a mouse thigh infection model. Louie A; Liu W; Kulawy R; Drusano GL Antimicrob Agents Chemother; 2011 Jul; 55(7):3453-60. PubMed ID: 21502615 [TBL] [Abstract][Full Text] [Related]
4. In vivo pharmacodynamics of a new oxazolidinone (linezolid). Andes D; van Ogtrop ML; Peng J; Craig WA Antimicrob Agents Chemother; 2002 Nov; 46(11):3484-9. PubMed ID: 12384354 [TBL] [Abstract][Full Text] [Related]
5. In Vitro and In Vivo Activities of a Bi-Aryl Oxazolidinone, RBx 11760, against Gram-Positive Bacteria. Barman TK; Kumar M; Mathur T; Chaira T; Ramkumar G; Kalia V; Rao M; Pandya M; Yadav AS; Das B; Upadhyay DJ; Hamidullah ; Konwar R; Raj VS; Singh H Antimicrob Agents Chemother; 2016 Dec; 60(12):7134-7145. PubMed ID: 27645240 [TBL] [Abstract][Full Text] [Related]
6. Oxazolidinone-containing Hybrids with Antibacterial Activity against Methicillin-resistant Staphylococcus aureus (MRSA): A Mini-review. Jiang D; Liu B; Gao T Curr Top Med Chem; 2021; 21(27):2440-2454. PubMed ID: 33185161 [TBL] [Abstract][Full Text] [Related]
7. In vivo antibacterial activity of MRX-I, a new oxazolidinone. Li CR; Zhai QQ; Wang XK; Hu XX; Li GQ; Zhang WX; Pang J; Lu X; Yuan H; Gordeev MF; Chen LT; Yang XY; You XF Antimicrob Agents Chemother; 2014; 58(4):2418-21. PubMed ID: 24395231 [TBL] [Abstract][Full Text] [Related]
8. In Vitro Activities of LCB 01-0648, a Novel Oxazolidinone, against Gram-Positive Bacteria. Oh SH; Kim J; Baek SY; Chae SE; Park HS; Cho YL; Kwak JH Molecules; 2017 Mar; 22(3):. PubMed ID: 28273820 [TBL] [Abstract][Full Text] [Related]
9. Linezolid activity against clinical Gram-positive cocci with advanced antimicrobial drug resistance in Iran. Houri H; Kazemian H; Sedigh Ebrahim-Saraie H; Taji A; Tayebi Z; Heidari H J Glob Antimicrob Resist; 2017 Sep; 10():200-203. PubMed ID: 28735054 [TBL] [Abstract][Full Text] [Related]
10. In vitro activity and microbiological efficacy of tedizolid (TR-700) against Gram-positive clinical isolates from a phase 2 study of oral tedizolid phosphate (TR-701) in patients with complicated skin and skin structure infections. Prokocimer P; Bien P; Deanda C; Pillar CM; Bartizal K Antimicrob Agents Chemother; 2012 Sep; 56(9):4608-13. PubMed ID: 22687509 [TBL] [Abstract][Full Text] [Related]
11. Comparative efficacies of human simulated exposures of tedizolid and linezolid against Staphylococcus aureus in the murine thigh infection model. Keel RA; Tessier PR; Crandon JL; Nicolau DP Antimicrob Agents Chemother; 2012 Aug; 56(8):4403-7. PubMed ID: 22687504 [TBL] [Abstract][Full Text] [Related]
12. Simple and Efficient Synthesis of 3-Aryl-2-oxazolidinone Scaffolds Enabling Increased Potency toward Biofilms. Ndukwe ARN; Hawas S; Qin J; Wiedbrauk S; Totsika M; Boase NRB; Fairfull-Smith KE Mol Pharm; 2023 Jul; 20(7):3484-3493. PubMed ID: 37289102 [TBL] [Abstract][Full Text] [Related]